Atlas Trials

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

Clinical trial NCT06031363 · COMPLETED

Trial details

NCT number
NCT06031363
Sponsor
The First Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
PancreatitisCholangiopancreatography, Endoscopic RetrogradeIndomethacin
Start date
2022-11-01
Primary completion
2023-12-06
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.